Pradžia › Ūmi limfoblastinė leukemija › New York
Ūmi limfoblastinė leukemija klinikiniai tyrimai New York
32 tyrimai dėl Ūmi limfoblastinė leukemija ieško dalyvių vietose New York.
Miestai New York
- New York City24 tyrimai
- Queens6 tyrimai
- The Bronx5 tyrimai
- Rochester4 tyrimai
- Buffalo4 tyrimai
- Greenburgh4 tyrimai
- New Rochelle3 tyrimai
- Staten Island3 tyrimai
Oficialus tyrimo tekstas (anglų kalba)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05334069A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai1 fazė
Amžius nuo 12 iki 78 · Visoms lytims · Atnaujinta 2026-09-29 · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Memorial Sloan Kettering Cancer Center -- Pediatrics, New York
Renkami dalyviai2 fazė
6 Months · Visoms lytims · Atnaujinta 2026-09-28 · NCT06514794Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
- Columbia University Medical Center, New York
Renkami dalyviaiStebimasis tyrimas
4 Weeks – 18 Years · Visoms lytims · Atnaujinta 2026-09-24 · NCT06529575Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Montefiore Einstein Comprehensive Cancer Center, The Bronx
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT06308588A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Montefiore Medical Center, New York
Renkami dalyviai1/2 fazė
30 Days · Visoms lytims · Atnaujinta 2026-09-16 · NCT04065399A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- The Mount Sinai Hospital, New York
Renkami dalyviai1 fazė
Amžius nuo 0 iki 18 · Visoms lytims · Atnaujinta 2026-09-16 · NCT06173518Cord Blood Transplant in Adults With Blood Cancers
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai2 fazė
Amžius nuo 21 iki 65 · Visoms lytims · Atnaujinta 2026-09-11 · NCT05884333First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-01 · NCT07586618The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- NYU Langone Hospital - Long Island, Mineola
- ir dar 7
Renkami dalyviai1/2 fazė
Iki 22 metų · Visoms lytims · Atnaujinta 2026-08-25 · NCT04726241A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
- Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ir dar 1
Renkami dalyviai2 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-08-20 · NCT07400029A Study of CTD402 in T-ALL/LBL Patients
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Einstein Comprehensive Cancer Center, The Bronx
Renkami dalyviai1/2 fazė
Amžius 1 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT07070219MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence
- Roswell Park Cancer Institute, Buffalo
Renkami dalyviaiLaukiami sveiki savanoriai
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-12 · NCT06323044Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Research Site, New York
Renkami dalyviai1/2 fazė
Amžius 16 ir vyresni · Visoms lytims · Atnaujinta 2026-07-20 · NCT07155226A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Roswell Park Cancer Institute, Buffalo
- North Shore University Hospital, Lake Sucess
- Cohen Children's Medical Center of New York, New Hyde
- ir dar 9
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-07-06 · NCT01351545A Study of Revumenib and Mezigdomide in People With Leukemia
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ir dar 1
Renkami dalyviai1/2 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-06-22 · NCT07356154TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai1/2 fazė
Iki 1 metų · Visoms lytims · Atnaujinta 2026-06-03 · NCT05848687European Prospective Investigation Into Childhood Cancer
- Columbia University Irving Medical Center, New York
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 3 iki 21 · Visoms lytims · Atnaujinta 2026-06-02 · NCT05375617Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
- University of Rochester, Rochester
- Stony Brook University Medical Center, Stony Brook
- ir dar 1
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-05-18 · NCT01790152Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Renkami dalyviai2 fazė
Iki 26 metų · Visoms lytims · Atnaujinta 2026-05-14 · NCT07566377A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Ascentage Investigative Site #1160, Stony Brook
- Ascentage Investigative Site #1151, The Bronx
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-30 · NCT06051409Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
- Roswell Park Comprehensive Cancer Center, Buffalo
Renkami dalyviai
Amžius nuo 3 iki 9 · Visoms lytims · Atnaujinta 2026-04-23 · NCT06074666Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
- The Mt. Hope Family Center, Rochester
Renkami dalyviai
Amžius nuo 8 iki 17 · Visoms lytims · Atnaujinta 2026-04-08 · NCT06956781A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Roswell Park Comprehensive Cancer Center, Buffalo
Renkami dalyviai1/2 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-03-24 · NCT04988555A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
- University of Rochester Medical Center, Wilmot Cancer Center, Rochester
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-18 · NCT06207123A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Memorial Sloan Kettering, New York
Renkami dalyviai2 fazė
Amžius nuo 18 iki 66 · Visoms lytims · Atnaujinta 2026-03-17 · NCT06859424Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai2 fazė
Amžius nuo 18 iki 54 · Visoms lytims · Atnaujinta 2026-03-17 · NCT06918431A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
- Memorial Sloan Kettering Cancer Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ir dar 1
Renkami dalyviai1 fazė
Amžius 17 ir vyresni · Visoms lytims · Atnaujinta 2026-02-10 · NCT06287528Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai1 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-01-08 · NCT04872478A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
- Columbia University Medical Center, New York
Renkami dalyviai
Amžius nuo 5 iki 21 · Visoms lytims · Atnaujinta 2025-10-07 · NCT05963971Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-04-15 · NCT06462365Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai1 fazė
Amžius nuo 1 iki 21 · Visoms lytims · Atnaujinta 2024-12-06 · NCT05476770Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.